“Inhibition of Toll-Like Receptor-4 Expression for Amelioration of Myocardial Injury in Diabetes: A Meta-Analysis”. Clinics, vol. 77, Nov. 2022, p. 100137, https://doi.org/10.1016/j.clinsp.2022.100137.